Performance of AZN AstraZeneca PLC ADR | 4.9% in 12m
Compare AZN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare AstraZeneca PLC ADR with its related Sector/Index XLV
Performance Duell AZN vs XLV
| TimeFrame | AZN | XLV |
|---|---|---|
| 1 Day | 0.19% | 0.03% |
| 1 Week | 7.19% | 0.34% |
| 1 Month | 11.0% | -5.26% |
| 3 Months | 13.6% | 0.15% |
| 6 Months | 23.3% | 14.58% |
| 12 Months | 4.93% | 6.54% |
| YTD | 11.6% | 1.21% |
| Rel. Perf. 1m | 1.42 | |
| Rel. Perf. 3m | 1.04 | |
| Rel. Perf. 6m | 0.52 | |
| Rel. Perf. 12m | -0.52 |
Is AstraZeneca PLC ADR a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, AstraZeneca PLC ADR (NASDAQ:AZN) is currently (April 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.95 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of April 2024 is 75.55. This means that AZN is currently overvalued and has a potential downside of 0.51% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZN as of April 2024 is 75.55. This means that AZN is currently overvalued and has a potential downside of 0.51% (Sold with Premium).
Is AZN a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: AZN is performing better - Values below 0%: AZN is underperforming
Compare AZN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.48% | 13.78% | -1.33% | -19.04% |
| US NASDAQ 100 | QQQ | 4.28% | 13.88% | -1.98% | -29.58% |
| US Dow Jones Industrial 30 | DIA | 7.21% | 14.78% | 4.29% | -9.34% |
| German DAX 40 | DBXD | 4.85% | 12.30% | 0.28% | -9.34% |
| UK FTSE 100 | ISFU | 4.70% | 9.92% | 7.01% | -1.52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.74% | 9.08% | 21.42% | 18.81% |
| Hongkong Hang Seng | HSI | 0.59% | 8.18% | 25.85% | 25.01% |
| Japan Nikkei 225 | EXX7 | 7.26% | 18.96% | 6.24% | -12.86% |
| India NIFTY 50 | INDA | 6.36% | 9.53% | 1.53% | -22.55% |
| Brasil Bovespa | EWZ | 5.48% | 13.66% | 14.20% | -13.45% |
AZN AstraZeneca PLC ADR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.52% | 12.85% | -4.31% | -30.06% |
| Consumer Discretionary | XLY | 4.02% | 15.29% | 5.26% | -14.97% |
| Consumer Staples | XLP | 6.60% | 11.96% | 8.08% | 4.46% |
| Energy | XLE | 7.03% | 9.54% | 8.18% | -11.42% |
| Financial | XLF | 7.31% | 14.04% | -7.60% | -20.33% |
| Health Care | XLV | 6.85% | 16.21% | 8.74% | -1.61% |
| Industrial | XLI | 6.14% | 13.57% | -4.96% | -19.79% |
| Materials | XLB | 6.66% | 14.58% | 2.61% | -8.49% |
| Real Estate | XLRE | 6.39% | 18.72% | 8.64% | 4.90% |
| Technology | XLK | 4.32% | 15.00% | -1.18% | -28.63% |
| Utilities | XLU | 6.95% | 10.13% | 8.62% | 5.67% |
| Aerospace & Defense | XAR | 4.75% | 14.08% | 1.64% | -14.64% |
| Biotech | XBI | 7.50% | 22.96% | -6.91% | 0.81% |
| Homebuilder | XHB | 4.43% | 18.00% | -25.85% | -42.54% |
| Retail | XRT | 4.74% | 18.25% | -3.95% | -15.99% |
Does AstraZeneca PLC ADR outperform its market, is AZN a Sector Leader?
No, over the last 12 months AstraZeneca PLC ADR (AZN) made 4.93%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.54%.
Over the last 3 months AZN made 13.60%, while XLV made 0.15%.
No, over the last 12 months AstraZeneca PLC ADR (AZN) made 4.93%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.54%.
Over the last 3 months AZN made 13.60%, while XLV made 0.15%.
| Period | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 10.95% | -5.26% | -2.83% |
| 3 Months | 13.60% | 0.15% | 3.78% |
| 12 Months | 4.93% | 6.54% | 23.97% |